Effectiveness of the Nicotine Inhaler for Smoking Cessation in an OTC Setting
Methods: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year.
Results: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was .77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low.
Conclusions: OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.
Document Type: Research Article
Affiliations: 1: Acting Associate Director, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD. 2: Public Health, Arizona Cancer Center, University of Arizona. 3: Department of Family and Community Medicine, University of Arizona. 4: Mel and Enid Zuckerman Arizona College of Public Health, University of Arizona, Tucson, AZ.
Publication date: 01 July 2004
The American Journal of Health Behavior seeks to improve the quality of life through multidisciplinary health efforts in fostering a better understanding of the multidimensional nature of both individuals and social systems as they relate to health behaviors.
The Journal aims to provide a comprehensive understanding of the impact of personal attributes, personality characteristics, behavior patterns, social structure, and processes on health maintenance, health restoration, and health improvement; to disseminate knowledge of holistic, multidisciplinary approaches to designing and implementing effective health programs; and to showcase health behavior analysis skills that have been proven to affect health improvement and recovery.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Review Board
- Reprints and Permissions
- Ingenta Connect is not responsible for the content or availability of external websites